retatrutide clinical trials brazil Retatrutide: A Promising Option for Non-Diabetic Weight Loss in Retatrutide Phase 3: TRIUMPH Program

In a phase 3 clinical trial, the medication retatrutide helped control blood sugar levels in participants with type 2 diabetes and led to an average of up to 36.6 pounds of weight loss, according to drugmaker Eli Lilly

Inflammatory bowel diseases 2016;22:207897

SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week Madison's Ozempic Journey Within the first week of starting, Madison noticed an immediate change

Because Retatrutide remains an investigational compound, any mention of an 8mg figure online reflects research reporting rather than an approved prescribing standard

However, these two treatments possess distinct characteristics that set them apart